Although no complement regulator polymorphisms for risk of colon cancer have been identified, CD46, CD55, and CD59 were all upregulated in colon cancer compared to adjacent healthy tissue (144, 145), with CD55 and CD59 expression correlating with tumor stage and differentiation level (146). This evidence concerns the gene CD46 and colonic neoplasm.